Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 5:09 AM
Ignite Modification Date:
2025-12-26 @ 4:13 AM
NCT ID:
NCT04950127
Pre Assignment Details:
This study was conducted in 2 parts: Part A and Part B. Participants were randomized in 1:1:1:1 ratio to receive either: linerixibat 40 milligram (mg) twice a day (BID) in Part A and Part B, linerixibat 40mg twice a day (BID) in Part A and placebo in Part B, placebo in Part A and Part B, or placebo in Part A and linerixibat 40mg twice a day (BID) in Part B.
Recruitment Details:
A total of 238 participants from Europe, North America, Latin America and Asia were enrolled and randomized.
Study:
NCT04950127
Study Brief:
Results Section:
NCT04950127